Senior Director, EpidemiologyRTI Health SolutionsWaltham, Massachusetts, United States
Disclosure information not submitted.
5C-04 - An Observational Postauthorization Safety Study to Assess Adverse Events of Special Interest in Recipients of Ad26.COV2.S in the United States
Tuesday, August 26, 20259:15 AM - 9:30 AM ET
5C-06 - Incidence Rates of Myocarditis/Pericarditis after Pfizer-BioNTech COVID-19 Vaccine in the United States: Interim Results From a Postapproval Safety Study, Primary Series Analysis
Tuesday, August 26, 20259:45 AM - 10:00 AM ET